|
1) Lucato LT, McKinney AM, Short J, et al. Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity. Australas Radiol. 2006; 50: 364-8
|
|
|
|
2) 森 墾. 5-FU脳症. In: 青木茂樹, 相田典子, 井田正博, 他, 編. 新版 よくわかる脳MRI. 第二版. 東京: 秀潤社; 2004
|
|
|
|
|
|
3) Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol. 2009; 63: 761-7
|
|
|
|
|
|
4) Tha KK, Terae S, Sugiura M, et al. Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta Neurol Scand. 2002; 106: 379-86
|
|
|
|
|
|
5) Ziereisen F, Dan B, Azzi N, et al. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features. Pediatr Radiol. 2006; 36: 205-12
|
|
|
|
|
|
6) Mizutani T. Drug-induced leukoencephalopathy. Nippon Rinsho. 2007; 65: 372-6
|
|
|
|
|
7) Yokoo H, Nakazato Y, Harigaya Y, et al. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report. Acta Neuropathol. 2007; 114: 425-30
|
|
|
|
|
|
8) Casey SO, Sampaio RC, Michel E, et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000; 21: 1199-206
|
|
|
|
|
|
9) Haykin ME, Gorman M, van Hoff J, et al. Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity. J Neurooncol. 2006; 76: 153-7
|
|
|
|
|
|
10) Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol. 2006; 111: 197-212
|
|
|
|
|
|
11) Dzudie A, Boissonnat P, Roussoulieres A, et al. Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine？: case reports. Transplant Proc. 2009; 41: 716-20
|
|
|
|
|
|
12) Frytak S, Moertel CH, Childs DS. Neurologic toxicity associated with high-dose metronidazole therapy. Ann Intern Med. 1978; 88: 361-2
|
|
|
|
|
|
13) Cecil KM, Halsted MJ, Schapiro M, et al. Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy. J Comput Assist Tomogr. 2002; 26: 948-51
|
|
|
|
|
|
14) Kim E, Na DG, Kim EY, et al. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol. 2007; 28: 1652-8
|
|
|
|
|
|
15) Olson EJ, Morales SC, McVey AS, et al. Putative metronidazole neurotoxicosis in a cat. Vet Pathol. 2005; 42: 665-9
|
|
|
|
|